8-K: Fuse Science Enters Receivership, Management Overhauled

Fuse Science, Inc. has been placed under court-ordered receivership, leading to the resignation of all prior officers and directors and the appointment of new interim management.

Summary

• Fuse Science, Inc. is now under court-ordered receivership following a District Court order on June 17, 2026.
• Peter D. Downey has been appointed as the Receiver, acting as an officer of the court.
• All previous officers and directors, including Lei Zhang (CEO), Meihua Xu (President, Treasurer), and Minming Yang (Company Secretary), have resigned or been removed by court order.
• Peter Downey has been appointed as Chairman of the Board, President, and Treasurer, effective June 24, 2026.
• Irina Veselinovic has been appointed as Secretary, effective June 24, 2026, and as Chief Financial Officer (CFO) effective June 29, 2026.
• A control block of 100,000 Preferred Shares Class D has been transferred to Fransys Consulting, Inc. as per court order.
• The company is working to regain access to its OTC Markets account to submit disclosures and update corporate information.
• New management is subject to limitations, requiring written approval from both the Secretary and Treasurer for certain actions by the President.

Sentiment

Score: 1

Explanation: StockSavvy.ai views this filing as extremely negative due to the company being placed under court-ordered receivership, insolvency, and the removal of all prior management.

Positives

• Appointment of a Receiver to manage the company's assets and affairs.
• New interim management appointed to stabilize operations.
• Court order provides a framework for managing the company's financial obligations and assets.
• Steps are being taken to notify relevant authorities and the transfer agent of management changes.
• Efforts are underway to restore access to OTC Markets for disclosure purposes.

Negatives

• The company has been placed under court-ordered receivership.
• The company is insolvent with $0 in assets and $0 in cash as of December 31, 2026.
• A judgment of $643,471 has been obtained against Fuse Science, Inc.
• Prior officers and directors have been removed by court order.
• The company's prior officers, directors, shareholders, agents, and employees are restrained from interfering with the Receiver's duties or transferring assets.
• The company has relocated its corporate headquarters and assets abroad.
• There is a substantial risk of asset dissipation, concealment, or improper transfer to insiders.

Risks

• Potential dissipation, concealment, or improper transfer of corporate assets to insiders.
• Inability to meet financial obligations as they become due.
• Irreparable harm to creditors if court intervention is absent.
• Uncertainty regarding the timing and outcome of regaining OTC Markets access.
• Potential challenges in maintaining or restoring the company's OTCID status.
• The Receiver's actions are subject to court supervision and control.
• Limitations on the President's authority require dual approval for significant financial actions.

Future Outlook

The company intends to continue the process of obtaining or re-establishing authorized access to its OTC Markets account to submit issuer disclosure materials, update corporate information, and take steps to maintain or restore its OTCID status. There is no assurance regarding the timing or outcome of these efforts.

Management Comments

• The Company believes that the appointment of the Receiver, the implementation of interim management, and the related corporate filings constitute material events for shareholders and the public market.
• The Company is providing this Current Report to give public notice of these developments and the Company's intended next steps.
• The Company intends to continue the process of obtaining or re-establishing authorized access to the Company's OTC IQ account and other OTC Markets issuer access points.
• The Company further intends to use such access, when available, to submit issuer disclosure materials, update corporate information, and take commercially reasonable steps intended to maintain or restore the Company's OTCID status, as applicable.
• There can be no assurance as to the timing or outcome of the OTC Markets access process, the Company's eligibility for any market tier, or the Company's ability to maintain any particular OTC Markets designation.
• The Company also intends to continue notifying applicable third parties, including the transfer agent, the State of Nevada, and OTC Markets, of the receivership, management changes, and other corporate updates reflected in the exhibits to this Current Report.

Industry Context

StockSavvy.ai notes that the appointment of a receiver and significant management overhaul often signals severe financial distress and a potential winding down of operations for companies in any industry, particularly those trading on OTC markets where transparency and operational stability are paramount.

Management Changes

Corporate Governance

Legal Proceedings

• District Court, Clark County, Nevada, Case No. A-25-912525-C: Order Granting Motion for Appointment of a Receiver for Defendant Fuse Science, Inc.
• Plaintiffs (MAR GROUP, MINA 12, WORLDWAYS INC., MAR CORPORATION) obtained a judgment against Fuse Science, Inc. for $643,471.

Related Party Transactions

• Transfer of 100,000 Preferred Shares Class D (control block) to Fransys Consulting, Inc. as per court order.

Stakeholder Impact

• Shareholders: Significant negative impact due to receivership, insolvency, and potential loss of investment.
• Creditors: Potential for partial recovery of debts through receivership process, but subject to court orders and asset availability.
• Employees: Uncertainty regarding continued employment and company operations.
• Management/Directors: Removal from positions and potential legal ramifications.

Next Steps

• Obtain or re-establish authorized access to the Company's OTC Markets account.
• Submit issuer disclosure materials and update corporate information on OTC Markets.
• Take steps to maintain or restore the Company's OTCID status.
• Notify the transfer agent, State of Nevada, and OTC Markets of the receivership and management changes.
• The Receiver will investigate asset transfers, stock issuances, and pursue recovery of improperly transferred assets.
• The Receiver will operate, manage, or wind down the business.
• The Receiver will prepare and file periodic reports with the Court.
• The Receiver may liquidate assets as necessary and distribute proceeds.

Key Dates

Recommendation

The company's placement under court-ordered receivership, confirmed insolvency with zero assets and cash, and the removal of all prior management indicate a severe financial crisis and a high probability of liquidation or significant restructuring that would likely render existing equity worthless.

Keywords

receivership, management change, Fuse Science, court order, interim management, corporate governance, financial distress, OTC Markets